Zura Bio (ZURA) Total Current Liabilities (2021 - 2026)

Zura Bio's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $11.7 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 44.32% year-over-year to $11.7 million in Q1 2026; TTM through Mar 2026 was $11.7 million, a 44.32% decrease from a year earlier, with the FY2025 full-year figure at $12.4 million, down 36.4% from the prior year.
• Total Current Liabilities slipped to $11.7 million in Q1 2026 per ZURA's latest filing, from $12.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $25.5 million in Q3 2025 and bottomed at $369439.0 in Q1 2022.
• The 5-year median for Total Current Liabilities is $15.1 million (2024), against an average of $13.9 million.
• Across the five-year window, Total Current Liabilities surged 5341.95% in 2022 and sank 44.32% in 2026, its largest moves.
• Year by year, Total Current Liabilities stood at $14.8 million in 2022, then jumped by 37.01% to $20.3 million in 2023, then slipped by 3.88% to $19.5 million in 2024, then tumbled by 36.4% to $12.4 million in 2025, then decreased by 5.36% to $11.7 million in 2026.
• Per Business Quant, the three latest ZURA Total Current Liabilities figures stand at $11.7 million (Q1 2026), $12.4 million (Q4 2025), and $25.5 million (Q3 2025).